Barclays Maintains Underweight on Omega Healthcare Invts, Lowers Price Target to $50

Benzinga Newsdesk www.benzinga.com Negative 54.1%

Neg 54.1% Neu 0% Pos 0%

Barclays analyst Richard Hightower maintains Omega Healthcare Invts (NYSE:OHI) with a Underweight and lowers the price target from $51 to $50.